Outcomes Associated with Generic Drugs Approved Using Product-Specific Determinations of Therapeutic Equivalence.

about

Prescription writing: Generic or brand?The Role of Prescribing Generic (Non-proprietary) Drugs in the Prevalence of Therapeutic Inertia in Multiple Sclerosis Care

P2860

Q42343400-4204E088-258D-4AD9-9FBA-AFAA3E728EDA Q58122615-3FA5466E-B100-4D51-A1AB-D27937F28BC3

P2860

Outcomes Associated with Generic Drugs Approved Using Product-Specific Determinations of Therapeutic Equivalence.

Item

http://www.wikidata.org/entity/Q38402776

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Outcomes Associated with Gener ...... ns of Therapeutic Equivalence.

@en

type

Item

label

Outcomes Associated with Gener ...... ns of Therapeutic Equivalence.

@en

prefLabel

Outcomes Associated with Gener ...... ns of Therapeutic Equivalence.

@en

P1476

Outcomes Associated with Gener ...... ons of Therapeutic Equivalence

@en

P2093

Jennifer M Polinski

http://www.w3.org/2001/XMLSchema#string

Jing Xie

http://www.w3.org/2001/XMLSchema#string

Joshua J Gagne

http://www.w3.org/2001/XMLSchema#string

Joyce Lii

http://www.w3.org/2001/XMLSchema#string

Lisa A Fulchino

http://www.w3.org/2001/XMLSchema#string

Sarah K Dutcher

http://www.w3.org/2001/XMLSchema#string

Wenlei Jiang

http://www.w3.org/2001/XMLSchema#string

P2860

Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration.

A systematic review of validated methods for identifying venous thromboembolism using administrative and claims data.

A systematic review of validated methods for identifying depression using administrative data.

A systematic review of validated methods for identifying suicide or suicidal ideation using administrative or claims data.

A combined comorbidity score predicted mortality in elderly patients better than existing scores.

Modified Regulatory Pathways to Approve Generic Drugs in the US and a Systematic Review of Their Outcomes.

Switch-backs associated with generic drugs approved using product-specific determinations of therapeutic equivalence.

Identification of fractures from computerized Medicare files.

Comparative effectiveness of generic and brand-name statins on patient outcomes: a cohort study.

Product-Specific Regulatory Pathways to Approve Generic Drugs: The Need for Follow-up Studies to Ensure Safety and Effectiveness.

P2888

s40265-017-0696-2

P304

427-433

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40265-017-0696-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Aaron S Kesselheim

P577

2017-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1083736220

http://www.w3.org/2001/XMLSchema#string

P698

28181177

http://www.w3.org/2001/XMLSchema#string

Outcomes Associated with Generic Drugs Approved Using Product-Specific Determinations of Therapeutic Equivalence.

about

P2860

P2860

Outcomes Associated with Generic Drugs Approved Using Product-Specific Determinations of Therapeutic Equivalence.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698